Federal Circuit hands victory to Snyders over heart valve patent

The US Court of Appeals for the Federal Circuit has held that claims of a patent covering an artificial heart valve were erroneously held to be unpatentable by the US Patent Trial and Appeal Board (PTAB), in a blow to a medical device company owned by Abbott Laboratories.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Medtech

Chinese invisible braces maker hits back at infringement claims

22 August 2025 The company has dismissed recent patent infringement claims from the Invisalign maker as “frivolous and entirely without merit,” pledging a vigorous defence.

Medtech

Invisalign maker sues Chinese rival in Europe, US, and China

21 August 2025 The $4 billion-a-year orthodontics company says its latest lawsuits defend “critical components” of its portfolio as rivals push cheaper alternatives.

Medtech

University files suit over AI ultrasound technology

30 May 2024 University of British Columbia alleges patent infringement by medtech companies | Suit concerns AI-driven ultrasound systems for cardiac imaging.

More features

Mental health in IP: ‘We have a clear picture of the problem’

From Edwards to Insulet: Three key medical device cases of 2025

Edwards v Meril: Behind the UPC’s landmark medtech showdown

5 ways the USPTO director is changing US innovation

EU unveils sweeping pharma, biotech, and medical device reforms

Mirum targets generics in quartet of suits over liver treatment

Hogan Lovells and Cadwalader strike historic deal to create $3.6bn firm

Edwards v Meril: 3 insights from the UPC Court of Appeal’s decision

Federal Circuit hands victory to Snyders over heart valve patent

More on this story

Editor's picks

Editor's picks

More features